Home Cart 0 Sign in  

[ CAS No. 139110-80-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 139110-80-8
Chemical Structure| 139110-80-8
Structure of 139110-80-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 139110-80-8 ]

Related Doc. of [ 139110-80-8 ]

Alternatived Products of [ 139110-80-8 ]

Product Details of [ 139110-80-8 ]

CAS No. :139110-80-8 MDL No. :MFCD00866966
Formula : C12H20N4O7 Boiling Point : -
Linear Structure Formula :- InChI Key :ARAIBEBZBOPLMB-UFGQHTETSA-N
M.W : 332.31 Pubchem ID :60855
Synonyms :
GG 167;GR 121167X
Chemical Name :(2R,3R,4S)-3-Acetamido-4-guanidino-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid

Calculated chemistry of [ 139110-80-8 ]

Physicochemical Properties

Num. heavy atoms : 23
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.58
Num. rotatable bonds : 8
Num. H-bond acceptors : 8.0
Num. H-bond donors : 8.0
Molar Refractivity : 75.65
TPSA : 198.22 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -10.44 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.07
Log Po/w (XLOGP3) : -2.98
Log Po/w (WLOGP) : -3.58
Log Po/w (MLOGP) : -3.18
Log Po/w (SILICOS-IT) : -3.12
Consensus Log Po/w : -2.56

Druglikeness

Lipinski : 2.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 3.0
Bioavailability Score : 0.17

Water Solubility

Log S (ESOL) : 0.51
Solubility : 1060.0 mg/ml ; 3.2 mol/l
Class : Highly soluble
Log S (Ali) : -0.62
Solubility : 79.4 mg/ml ; 0.239 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 1.64
Solubility : 14300.0 mg/ml ; 43.2 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 4.84

Safety of [ 139110-80-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 139110-80-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 139110-80-8 ]

[ 139110-80-8 ] Synthesis Path-Downstream   1~71

  • 1
  • [ 1184-90-3 ]
  • sodium 5-acetamido-4-amino-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonate [ No CAS ]
  • [ 139110-80-8 ]
  • 2
  • [ 1184-90-3 ]
  • [ 130525-62-1 ]
  • [ 139110-80-8 ]
  • 3
  • [ 130525-62-1 ]
  • [ 66356-40-9 ]
  • [ 139110-80-8 ]
  • 4
  • [ 139110-80-8 ]
  • 5-acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-L-arabino-hept-2-enonic acid [ No CAS ]
  • 5
  • [ 149398-58-3 ]
  • [ 139110-80-8 ]
YieldReaction ConditionsOperation in experiment
69% Step E: Preparation of zanamivirIn a reaction vessel, 7.3 g of the solid residue, from step D, was taken and to it 7.3 g of ammonium formate along with 140 ml ammonia added at 25C - 3O0C. The reaction mass was heated to 900C for 3 hrs. 0.7 g of charcoal was added to this reaction mass and content was stirred for about 1 hr. Then the mass was cooled to 20C - 25C and filtered. The filtrate was concentrated at 600C under vacuum to obtain residue in which 100 ml of methanol was added and stirred. The resulting solid was filtered and dried under vacuum to yield 5.0 g of the title compound (yield - 69%, HPLC purity - 85%).
69% In a reaction vessel, 7.3 g of the solid residue, from step D, was taken and to it 7.3 g of ammonium formate along with 140 ml ammonia added at 25 C.-30 C. The reaction mass was heated to 90 C. for 3 hrs. 0.7 g of charcoal was added to this reaction mass and content was stirred for about 1 hr. Then the mass was cooled to 20 C.-25 C. and filtered. The filtrate was concentrated at 60 C. under vacuum to obtain residue in which 100 ml of methanol was added and stirred. The resulting solid was filtered and dried under vacuum to yield 5.0 g of the title compound (yield-69%, HPLC purity-85%).
  • 6
  • [ 913745-34-3 ]
  • [ 139110-80-8 ]
YieldReaction ConditionsOperation in experiment
88% With 1,8-diazabicyclo[5.4.0]undec-7-ene; at 5 - 20℃; for 0.5h; Process for the preparation of 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-P-glycero-D-galacto-non-enonic acid (Formula I); Charged DBU (22.48 gm) in a vessel containing 5-acetamido-4-guanidino-6-(1,2,3-triacetoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylate (as prepared in example-2) slowly at temp 5-10 C. Subsequently, the temperature was raised up to RT and maintained for 30 min. The reaction mass was washed with MDC and subsequently, acetone was added. The product thus obtained was isolated. The compound was filtered, washed with acetone and dried under reduced pressure at 50 C. The yield was 6.7 g (61.3%). HPLC Purity-99.5%
61.3% With 1,8-diazabicyclo[5.4.0]undec-7-ene; at 5 - 25℃; for 0.5h;Product distribution / selectivity; Example-6: Process for the preparation of 5-(acetylamino)-4- [(aminoiminomethyl)aminol-2,6-anhvdro-3,4,5-trideoxy-D-glycero-D-galacto-non- enonic acid (Formula I) Charged DBU (22.48gm) in a vessel containing 5-acetamido-4-guanidino-6- (l,2,3-triacetoxypropyl)-5,6-dihydro-4H-pyran-2-carboxylate (as prepared in example- 2) slowly at temp 5-10 C. Subsequently, the temperature was raised up to RT and maintained for 30 min. The reaction mass was washed with MDC and subsequently, acetone was added. The product thus obtained was isolated. The compound was filtered, washed with acetone and dried under reduced pressure at 50 C.The yield was 6.7 g (61.3 %). HPLC Purity - 99.5%
  • 7
  • C17H35BrO [ No CAS ]
  • [ 139110-80-8 ]
  • C29H54N4O8 [ No CAS ]
  • 8
  • [ 126614-26-4 ]
  • [ 139110-80-8 ]
  • C31H58N4O8 [ No CAS ]
  • 9
  • [ 139110-80-8 ]
  • [ 343248-28-2 ]
  • C32H60N4O8 [ No CAS ]
YieldReaction ConditionsOperation in experiment
cellulose acetate and polyethylene glycol 400 are added to acetone and mixed thoroughly to form a polymer solution.
YieldReaction ConditionsOperation in experiment
With pyrographite; In water; isopropyl alcohol; at 20 - 90℃;Purification / work up; Step F: Purification of <strong>[139110-80-8]zanamivir</strong>Crude <strong>[139110-80-8]zanamivir</strong> (5 g), from earlier step, was stirred with 50 ml of water and heated to 900C to get suspension. To it 4 g charcoal was added and filtered hot through hyflo to get a clear solution. To the clear filtrate 15 ml of isopropyl alcohol was added dropwise. The solid thus obtained was filtered, washed with isopropyl alcohol and dried under vacuum at 60C to obtain 2.5 g of pure <strong>[139110-80-8]zanamivir</strong> (HPLC purity - 99.5%).
  • 20
  • amantadine-C7-Neu5Ac [ No CAS ]
  • [ 139110-80-8 ]
  • C31H48N6O12 [ No CAS ]
YieldReaction ConditionsOperation in experiment
Example 8Preparation of Compound [amantadine-C7-Neu5Ac-Ci2 20N4Oy] having the following structural formula:The compound obtained from the previous phase (amantadine-C7-Neu5Ac) is dissolved in 10 ml of distilled water and 2.69 g of C12H20N4O7 {CAS[ 139110-80-8] ; M .W. 332.30} are added . Incubate the sample during 2 hours at 60C under stirring . Add 1.37 g of sodium cyanoborohydride (NaBH3CN) . Incubate the sample at 60 C under stirring overnight.Centrifugate and eliminate the supernatant. Wash at least once with 30 and 50 ml of distilled water. Centrifugate again and eliminate the supernatant. Add 50 ml of the solvent mixture chloroform : methanol : NH4OH 15 M (60 : 35 : 8 ; V/V/V) . Incubate the sample during 1 hour at room temperature under stirring . Centrifugate, dry the supranatant into a rotating desiccator. Place the dried sample in a minimum volume of water. Lyophilize and store the sa m ple in freezer at -20 C.
  • 21
  • rimantadine-C7-Neu5Ac [ No CAS ]
  • [ 139110-80-8 ]
  • C33H52N6O12 [ No CAS ]
YieldReaction ConditionsOperation in experiment
Example 13Preparation of Compound [rimantadine-C7-Neu5Ac-Ci2H20N4O7] having the following structural formula:The compound obtained from the previous phase (rimantadine-C7-Neu5Ac) is dissolved in 10 ml of distilled water and 2.69 g of C12H20N4O7 {CAS[ 139110-80-8] ; M .W. 332.30} are added . Incubate the sample during 2 hours a 60 C under stirring . Add 1.37 g of sodium cyanoborohydride(NaBH3CN) . Incubate the sample at 60C under stirring overnight.Centrifugate and eliminate the supernatant. Wash at least once with 30 and 50 ml of distilled water. Centrifugate again and eliminate the supernatant. Add 50 ml of the solvent mixture Chloroform : Methanol : NH4OH 15 M (60 : 35 : 8 ; V/V/V) . Incubate the sample during 1 hour at room temperature under stirring . Centrifugate, dry the supernatant into a rotating desiccator. Place the dried sample in a minimum volume of water. Lyophilize and store the sample in freezer at -20 C.
  • 22
  • [ 1228216-82-7 ]
  • [ 139110-80-8 ]
  • 23
  • [ 1372800-41-3 ]
  • [ 139110-80-8 ]
  • 24
  • [ 1372800-42-4 ]
  • [ 139110-80-8 ]
  • 25
  • [ 1372800-43-5 ]
  • [ 139110-80-8 ]
  • 26
  • [ 1372800-46-8 ]
  • [ 139110-80-8 ]
  • 27
  • [ 203119-47-5 ]
  • [ 139110-80-8 ]
  • 28
  • [ 1372800-32-2 ]
  • [ 139110-80-8 ]
  • 29
  • C16H23NO3 [ No CAS ]
  • [ 139110-80-8 ]
  • 30
  • [ 1372800-34-4 ]
  • [ 139110-80-8 ]
  • 31
  • [ 1372800-35-5 ]
  • [ 139110-80-8 ]
  • 32
  • C29H35NO4 [ No CAS ]
  • [ 139110-80-8 ]
  • 33
  • C37H53NO7Si [ No CAS ]
  • [ 139110-80-8 ]
  • 34
  • [ 1372800-36-6 ]
  • [ 139110-80-8 ]
  • 35
  • C39H53NO8Si [ No CAS ]
  • [ 139110-80-8 ]
  • 36
  • C33H39NO8 [ No CAS ]
  • [ 139110-80-8 ]
  • 37
  • [ 1372800-37-7 ]
  • [ 139110-80-8 ]
  • 38
  • [ 1192409-04-3 ]
  • [ 139110-80-8 ]
  • 39
  • [ 1372800-38-8 ]
  • [ 139110-80-8 ]
  • 40
  • [ 1372800-39-9 ]
  • [ 139110-80-8 ]
  • 41
  • [ 1372800-40-2 ]
  • [ 139110-80-8 ]
  • 42
  • [ 107020-87-1 ]
  • [ 139110-80-8 ]
  • 43
  • [ 110481-26-0 ]
  • [ 139110-80-8 ]
  • 44
  • methyl-5-acetamido-3,4,5-trideoxy-D-manno-nonulopyranosonate [ No CAS ]
  • [ 139110-80-8 ]
  • 45
  • [ 4023-02-3 ]
  • [ 139110-70-6 ]
  • [ 139110-80-8 ]
YieldReaction ConditionsOperation in experiment
52% To a solution of amine 12 (300 mg, 0.7 mmol) and 1H-pyrazole-1-carboxamidine (310 mg, 2.1 mmol) in anhydrous DMF (2 mL) was added N,N-diisopropylethylamine (0.36 mL, 2.1 mmol). The mixture was stirred at room temperature for 96 h. During this period, two additional batches of 1H-pyrazole-1-carboxamidine hydrochloride (103 mg, 0.7 mmol) and N,N-diisopropylethylamine (0.12 mL, 0.7 mmol) in DMF (0.5 mL) were added at 48 h and 72 h, respectively. Methanol (15 mL), water (6 mL), and 10% NaOH solution (2 mL) were added, and the mixture was stirred for additional 12 h. Acetic acid was then added until pH 7.5. The solvent was removed by concentration under reduced pressure at 40 C. The residue was filtered, and the filtrate was applied to a column of Dowex 50WX8-200 (H+) resin and washed with water until neutralization. The column was then eluted with 1.5 N aqueous ammonium hydroxide, and the combined fractions were concentrated. The residue was recrystallized by isopropanol/water (3:1) to afforded zanamivir as a white solid (120 mg, 52%). Mp 252-254 C; +40.5 (c 1.0, H2O); 1H NMR (300 MHz, D2O): delta 5.61 (d, J=2.1 Hz, 1H), 4.44 (dd, J=2.1, 9.3 Hz, 1H), 4.37 (dd, J=1.2, 10.8 Hz, 1H), 4.21 (t, J=9.6 Hz, 1H), 3.92-3.98 (m, 1H), 3.88 (dd, J=3.7, 12 Hz, 1H), 3.61-3.67 (m, 2H), 2.02 (s, 3H); 13C NMR (75 MHz, D2O): delta 175.5, 170.3, 158.1, 150.4, 105.0, 76.5, 70.9, 69.2, 64.2, 52.2, 48.9, 23.1; Anal. Calcd for C12H20N4O7·1.17H2O: C, 40.78, H, 6.37, N, 15.85; found: C, 40.62, H, 6.37, N, 15.57; MS (ESI, m/z): 333.00 [M+H]+; ESI-HRMS calcd for C12H20N4O7Na [M+Na]+ 355.1230, found 355.1234.
  • 47
  • (1S,2R)-1-((2R,3R,4S)-3-acetamido-4-(2,3-bis(tert-butoxycarbonyl)guanidino)-6-(methoxycarbonyl)-3,4-dihydro-2H-pyran-2-yl)propane-1,2,3-triyl triacetate [ No CAS ]
  • [ 139110-80-8 ]
  • 48
  • C17H28N4O9 [ No CAS ]
  • [ 139110-80-8 ]
  • 49
  • (2R,3R,4S)-3-acetamido-4-((tert-butoxycarbonyl)amino)-2-((S)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(methoxymethoxy)methyl)-3,4-dihydro-2H-pyran-6-carboxylic acid [ No CAS ]
  • [ 139110-80-8 ]
  • 50
  • (2R,3R,4S)-3-acetamido-6-carboxy-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-4-aminium hydrochloride [ No CAS ]
  • [ 4023-02-3 ]
  • [ 139110-80-8 ]
  • 51
  • (S)-tert-butyl (1-nitro-4-oxopentan-2-yl)carbamate [ No CAS ]
  • [ 139110-80-8 ]
  • 52
  • tert-butyl ((2R,3R,4S)-2-((S)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(methoxymethoxy)methyl)-6-methyl-3-nitro-3,4-dihydro-2H-pyran-4-yl)carbamate [ No CAS ]
  • [ 139110-80-8 ]
  • 54
  • tert-butyl ((2R,3R,4S)-3-amino-2-((S)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(methoxymethoxy)methyl)-6-methyl-3,4-dihydro-2H-pyran-4-yl)carbamate [ No CAS ]
  • [ 139110-80-8 ]
  • 55
  • tert-butyl ((2R,3R,4S)-3-acetamido-2-((S)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(methoxymethoxy)methyl)-6-methyl-3,4-dihydro-2H-pyran-4-yl)carbamate [ No CAS ]
  • [ 139110-80-8 ]
  • 56
  • tert-butyl ((2R,3R,4S)-3-acetamido-2-((S)-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)(methoxymethoxy)methyl)-6-formyl-3,4-dihydro-2H-pyran-4-yl)carbamate [ No CAS ]
  • [ 139110-80-8 ]
  • 57
  • [ 139110-80-8 ]
  • (2R,3R,4S)-3-acetamido-4-guanidino-N-(methylsulfonyl)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxamide [ No CAS ]
  • 58
  • [ 139110-80-8 ]
  • [ 212555-23-2 ]
  • (2R,3R,4S)-S-2,4,6-trimethoxybenzyl-3-acetamido-4-guanidino-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carbothioate [ No CAS ]
YieldReaction ConditionsOperation in experiment
92% With 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride; In dimethyl sulfoxide; at 20℃; for 24h; DMSO (3 mL) was added to <strong>[139110-80-8]zanamivir</strong> hydrate (120 mg, 0.34 mmol as a monohydrate), dissolved by heating, and then cooled to room temperature. To this solution, 2,4,6-trimethoxybenzyl thiol (364 mg, 1.7 mmol) and DMT-MM (141 mg, 0.51 mmol) were added and the mixture was stirred at room temperature for 24 hours. DMT-MM (70 mg, 0.25 mmol) was added respectively after 4 hours and 8 hours. To this reaction solution was added ion exchanged water(30 mL) was added, and after washing 5 times with CHCl 3 (10 mL), the aqueous layer was evaporated. Subsequently, DMSO in the residue was distilled off under reduced pressure in vacuo. The residue was dissolved in a small amount of MeOH and reprecipitated from EtOAc, and the produced solid was filtered off and dried in vacuo to give a pale yellow solid [1e] (165 mg, 92%).
  • 59
  • [ 166197-22-4 ]
  • [ 130525-62-1 ]
  • [ 139110-80-8 ]
YieldReaction ConditionsOperation in experiment
74.9% With sodium carbonate; In water; at 35℃; for 7h;Industrial scale; 1.4 kg of 2,3-didehydro-4-amino-4-acety lneuraminic acid (Formula la) was added 30l of glass reactor , 15 kg of water was added , then 1.3 kg of sodium carbonate was added, and followed by the addition 800 g of imidopyridine hydrochloride at 40 C , and reaction was carried out for 6 hours. the 8 kg of water was concentrated and 13 kg of isopropyl alcohol was added and stirred to precipitate a solid powder. filtered , washed with isopropanol and dried to obtain 67 g of crude Zanamivir . then recrystallized from isopropanol-water , filtrated , and dried to obtain a pharmaceutical grade of zanamivir (formula I) 1. kg Yield: 74.9%
  • 60
  • C18H23NO10 [ No CAS ]
  • [ 139110-80-8 ]
  • 61
  • [ 19342-33-7 ]
  • [ 139110-80-8 ]
  • 62
  • [ 139110-80-8 ]
  • [ 405-50-5 ]
  • C20H25FN4O8 [ No CAS ]
YieldReaction ConditionsOperation in experiment
71.5% 1) Accurately weigh 118.2 mg (0.767 mmol) of 4-fluorophenylacetic acid,DCC 186.1 mg (0.902 mmol) was placed in a round bottom flask.Then add 3.0mL anhydrous dimethyl sulfoxide to dissolve and mix, stir well, vacuum, nitrogen protection,The reaction was carried out at room temperature for 1 hour to give an active ester.(2) Accurately weighed <strong>[139110-80-8]zanamivir</strong> 150.0 mg (0.451 mmol) and dissolve it with 2 ml dimethyl sulfoxide.Slowly added to the active ester reaction solution,Then, 0.13 mL of triethylamine and 2.75 mg (0.022 mmol) of DMAP were added dropwise, mixed, and stirred well.Empty space, nitrogen protection, reaction at room temperature for 15 hours,The reaction was complete as monitored by TLC (ethyl acetate: methanol: water = 4:2:1).(3) After the reaction is finished, use medium-speed filter paper to filter and remove most of the urea byproducts;Dichloromethane and water were added to the filtrate and extracted to remove unreacted 4-fluorophenylacetic acid and active esters.Obtain the aqueous phase, filter the medium-speed filter,The urea byproduct was removed and the filtrate was removed by rotary evaporation at room temperature to remove the dichloromethane.Then it is frozen in a refrigerator at -80 degrees Celsius for 12 hours.After freeze-drying in a lyophilizer for 2 days, a white powdery product was obtained with a final yield of 71.5%.
A DMSO solution (3 mL) containing HoBt (121.8 mg, 0.902 mmol),DCC (186.1 mg, 0.902 mmol), and 2-(4-fluorophenyl) acetic acid(118.2 mg, 0.767 mmol) was stirred at 25 C. After stirring for 1 h, asolution of <strong>[139110-80-8]zanamivir</strong> (150.0 mg, 0.451 mmol) in DMSO (2 mL) andEt3N (0.13 mL) was slowly added to the above solution under nitrogenprotection and the solution stirred at 25 C for 24 h. The process wasmonitored by TLC. The crystals were filtered and washed on the filterwith water (2 mL). The filtrate was extracted with EtOAc and H2O(10 mL×3). The combined water layer was concentrated under reducedpressure and freeze-dried in lyophilizer for 24 h. The crudeproduct was purified by a column of Sephadex LH-20 (EtOH/H2O=5/95) to afford target product compound 45a. The synthesis and purificationsteps of 45b are similar to that of 45a.
  • 63
  • C32H50N4O13 [ No CAS ]
  • [ 139110-80-8 ]
  • 64
  • C38H48N4O14 [ No CAS ]
  • [ 139110-80-8 ]
  • 65
  • C27H42N4O11 [ No CAS ]
  • [ 124-07-2 ]
  • [ 139110-80-8 ]
  • 66
  • C33H40N4O12 [ No CAS ]
  • [ 22204-53-1 ]
  • [ 139110-80-8 ]
  • 67
  • 5-acetamido-4-(3-octanoylguanidino)-6-(1,2,3-trihydroxypropyl)-4,5-dihydro-6H-pyran-2-carboxylic acid [ No CAS ]
  • [ 124-07-2 ]
  • [ 139110-80-8 ]
  • 68
  • 5-acetamido-4-(3-(2-(6-methoxynaphthalen-2-yl)propanoyl))guanidino-6-(1,2,3-trihydroxypropyl)-4,5-dihydro-6H-pyran-2-carboxylic acid [ No CAS ]
  • [ 22204-53-1 ]
  • [ 139110-80-8 ]
  • 69
  • C20H33N3O9S [ No CAS ]
  • [ 139110-80-8 ]
  • C28H46N6O12S [ No CAS ]
YieldReaction ConditionsOperation in experiment
11% A mixture of 13 (100?mg, 0.26?mmol), HATU (117?mg, 0.30?mmol) and DIPEA (0.15?ml, 0.8?mmol) in anhydrous DMF (10?ml) was stirred under nitrogen at 0?C for 30?min then a solution of Relenza (97?mg, 0.29?mmol) in the mixture of dry DMF:DMSO(10?ml, 8:2) was added and stirring was continued for another 3 days at room temperature. The reaction mixture were filtered off and the filtrate, plus a DMF washing, was evaporated in vacuo to get crude oil, which was further purified by chromatography, eluting with neat EtOAC to 1:1 (MeOH: EtOAC) to give desired product as an off white solid (20?mg, 11%). M. p. 282-284?C. Rf 0.40 [MeOH-EtOAc 3:7]. [alpha]D25 (CH3OH; c?=?0.028): 35.71. upsilonmax (neat)/cm-1 3668, 3244, 2988, 2972, 2901, 1704, 1689, 1568, 1453,1405, 1322, 1250, 1155, 1049, 894, 609, 548. deltaH (300?MHz, CD3OD): 1.40 (22H, s), 2.00 (5H, s), 2.65 (1H, s), 3.00-3.10 (2H, m), 3.40 (1H, br s, -OH), 3.60-3.75 (1H, m, 3.75-3.90 (1H, m), 4.00-4.25 (4H, m), 4.30-4.50 (3H, m), 5.20-5.25 (1H, m), 5.50 (1H, s). deltaC (75?MHz, D2O): 21.8, 26.9, 27.4, 47.6, 48.0, 51.0, 62.9, 67.9, 69.6, 75.2, 82.0, 103.8, 130.0, 149.0, 152.0, 156.8, 170.0, 174.2, 184.0. MS: C28H46N6O12?S?m/z (ES+) 691.3 [M + H+]. HRMS Calculated for C28H47N6O12S 691.2967, found 691.2973.
  • 70
  • C20H33N3O9S [ No CAS ]
  • [ 139110-80-8 ]
  • C19H30N6O10S*CH2O2 [ No CAS ]
  • 71
  • [ 58574-03-1 ]
  • [ 139110-80-8 ]
  • C25H28N4O9 [ No CAS ]
YieldReaction ConditionsOperation in experiment
General procedure: A DMSO solution (3 mL) containing HoBt (121.8 mg, 0.902 mmol),DCC (186.1 mg, 0.902 mmol), and 2-(4-fluorophenyl) acetic acid(118.2 mg, 0.767 mmol) was stirred at 25 C. After stirring for 1 h, asolution of <strong>[139110-80-8]zanamivir</strong> (150.0 mg, 0.451 mmol) in DMSO (2 mL) andEt3N (0.13 mL) was slowly added to the above solution under nitrogenprotection and the solution stirred at 25 C for 24 h. The process wasmonitored by TLC. The crystals were filtered and washed on the filterwith water (2 mL). The filtrate was extracted with EtOAc and H2O(10 mL×3). The combined water layer was concentrated under reducedpressure and freeze-dried in lyophilizer for 24 h. The crudeproduct was purified by a column of Sephadex LH-20 (EtOH/H2O=5/95) to afford target product compound 45a. The synthesis and purificationsteps of 45b are similar to that of 45a.
Same Skeleton Products
Historical Records

Similar Product of
[ 139110-80-8 ]

Chemical Structure| 1276528-62-1

A1269620[ 1276528-62-1 ]

Zanamivir-13C,15N2

Reason: Stable Isotope

Chemical Structure| 1260601-68-0

A757036[ 1260601-68-0 ]

(2R,3R,4S)-3-Acetamido-4-guanidino-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid hydrate

Reason: Hydrate